NYSE:SEM - Select Medical Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $40.00
  • Forecasted Upside: -4.74 %
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
▲ +1.18 (2.89%)

This chart shows the closing price for SEM by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Select Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SEM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SEM

Analyst Price Target is $40.00
▼ -4.74% Downside Potential
This price target is based on 4 analysts offering 12 month price targets for Select Medical in the last 3 months. The average price target is $40.00, with a high forecast of $46.00 and a low forecast of $34.00. The average price target represents a -4.74% upside from the last price of $41.99.

This chart shows the closing price for SEM for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 4 contributing investment analysts is to buy stock in Select Medical. This rating has held steady since August 2019, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/17/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$42.00 ➝ $46.00Medium
5/13/2021BenchmarkBoost Price TargetBuy$40.00 ➝ $44.00High
5/10/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$42.00 ➝ $46.00Medium
3/1/2021Credit Suisse GroupBoost Price TargetNeutral$32.00 ➝ $34.00Low
2/26/2021Bank of AmericaUpgradeUnderperform ➝ Buy$30.00 ➝ $36.00High
2/17/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$27.00 ➝ $34.00Low
1/5/2021Credit Suisse GroupBoost Price TargetNeutral$22.00 ➝ $27.00N/A
11/2/2020Credit Suisse GroupBoost Price TargetNeutral$19.00 ➝ $22.00High
8/4/2020Deutsche Bank AktiengesellschaftBoost Price TargetPositive ➝ Buy$24.00 ➝ $26.00Low
8/3/2020Credit Suisse GroupBoost Price TargetNeutral$18.00 ➝ $19.00Low
6/16/2020Bank of AmericaDowngradeNeutral ➝ Underperform$18.00 ➝ $15.00High
5/4/2020Credit Suisse GroupLower Price TargetNeutral$23.00 ➝ $18.00Low
5/4/2020Wells Fargo & CompanyLower Price TargetOverweight$31.00 ➝ $24.00High
4/24/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$33.00 ➝ $24.00High
4/20/2020Royal Bank of CanadaReiterated RatingBuy$26.00Low
4/3/2020Credit Suisse GroupLower Price TargetNeutral$29.00 ➝ $23.00High
3/24/2020BenchmarkLower Price TargetBuy$33.00 ➝ $25.00High
2/24/2020Royal Bank of CanadaReiterated RatingOutperform ➝ Positive$32.00High
2/24/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuy$22.00 ➝ $33.00High
1/28/2020Royal Bank of CanadaReiterated RatingOutperform$27.00High
11/1/2019Credit Suisse GroupSet Price TargetHold$18.00High
9/16/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuy$22.00Low
5/17/2019JMP SecuritiesUpgradeMarket Perform ➝ Outperform$18.00Medium
5/9/2019BarclaysReiterated RatingHold$16.00Low
1/7/2019Credit Suisse GroupLower Price TargetNeutral ➝ Neutral$21.00 ➝ $16.00High
12/14/2018BarclaysInitiated CoverageEqual Weight ➝ Equal Weight$20.00High
11/5/2018Credit Suisse GroupBoost Price TargetNeutral ➝ Neutral$18.00 ➝ $21.00Medium
10/16/2018Credit Suisse GroupInitiated CoverageNeutral ➝ Neutral$18.00Medium
2/27/2018JMP SecuritiesUpgradeUnderperform ➝ Market Perform$12.00Low
2/23/2018Robert W. BairdReiterated RatingBuy$26.00Low
1/30/2018Wells Fargo & CompanyInitiated CoverageOutperform ➝ Outperform$26.00High
1/4/2018Bank of AmericaUpgradeUnderperform ➝ Neutral$19.00Medium
11/6/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$22.00N/A
10/23/2017Robert W. BairdSet Price TargetBuy$25.00N/A
10/17/2017Robert W. BairdReiterated RatingBuy$21.00N/A
10/13/2017Royal Bank of CanadaReiterated RatingBuy$19.00N/A
9/13/2017Royal Bank of CanadaReiterated RatingBuy$19.00Low
8/7/2017JMP SecuritiesBoost Price TargetMarket Underperform$10.00 ➝ $12.00High
8/7/2017Deutsche Bank AktiengesellschaftBoost Price TargetHold$20.00 ➝ $22.00Low
8/7/2017BenchmarkBoost Price TargetBuy ➝ Buy$17.00 ➝ $20.00High
8/7/2017Robert W. BairdUpgradeNeutral ➝ Outperform$15.00 ➝ $21.00High
3/31/2017BenchmarkInitiated CoverageBuy ➝ Buy$16.00Medium
1/30/2017Wells Fargo & CompanyDowngradeOutperform ➝ Market PerformN/A
1/3/2017Royal Bank of CanadaReiterated RatingBuy$17.00N/A
11/11/2016UBS GroupSet Price TargetSell$10.00N/A
9/28/2016JMP SecuritiesDowngradeMarket Perform ➝ Underperform$10.00N/A
8/22/2016UBS GroupReiterated RatingSellN/A
7/26/2016UBS GroupReiterated RatingSell$11.00N/A
(Data available from 6/21/2016 forward)
Select Medical logo
Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. The company's Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma. Its Rehabilitation Hospital segment offers therapy and rehabilitation treatments, including rehabilitative services for brain and spinal cord injuries, strokes, amputations, neurological disorders, orthopedic conditions, pediatric congenital or acquired disabilities, and cancer. The company's Outpatient Rehabilitation segment operates rehabilitation clinics that provide physical, occupational, and speech rehabilitation programs and services; and specialized programs, such as functional programs for work related injuries, hand therapy, post-concussion rehabilitation, pediatric and cancer rehabilitation, and athletic training services. Its Concentra segment operates and provides occupational health centers and contract services at employer worksites that deliver occupational medicine, physical therapy, and consumer health services, as well as provides veterans' healthcare services. As of December 31, 2020, the company operated 99 critical illness recovery hospitals in 28 states; 30 rehabilitation hospitals in 12 states; 1,788 outpatient rehabilitation clinics in 37 states and the District of Columbia; and 517 occupational health centers, and 134 onsite clinics at employer worksites states. Select Medical Holdings Corporation was founded in 1996 and is headquartered in Mechanicsburg, Pennsylvania.
Read More

Today's Range

Now: $41.99
Low: $40.97
High: $42.76

50 Day Range

MA: $38.48
Low: $34.41
High: $42.67

52 Week Range

Now: $41.99
Low: $13.51
High: $43.25


1,513,090 shs

Average Volume

718,698 shs

Market Capitalization

$5.66 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Select Medical?

The following Wall Street sell-side analysts have issued reports on Select Medical in the last twelve months: Bank of America Co., Benchmark Co., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, and Zacks Investment Research.
View the latest analyst ratings for SEM.

What is the current price target for Select Medical?

4 Wall Street analysts have set twelve-month price targets for Select Medical in the last year. Their average twelve-month price target is $40.00, suggesting a possible downside of 2.0%. Deutsche Bank Aktiengesellschaft has the highest price target set, predicting SEM will reach $46.00 in the next twelve months. Credit Suisse Group AG has the lowest price target set, forecasting a price of $34.00 for Select Medical in the next year.
View the latest price targets for SEM.

What is the current consensus analyst rating for Select Medical?

Select Medical currently has 1 hold rating and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe SEM will outperform the market and that investors should add to their positions of Select Medical.
View the latest ratings for SEM.

What other companies compete with Select Medical?

How do I contact Select Medical's investor relations team?

Select Medical's physical mailing address is 4714 GETTYSBURG ROAD P.O. BOX 2034, MECHANICSBURG PA, 17055. The health services provider's listed phone number is 717-972-1100 and its investor relations email address is [email protected] The official website for Select Medical is www.selectmedicalcorp.com.